Ke Gong

1.6k total citations · 1 hit paper
39 papers, 1.0k citations indexed

About

Ke Gong is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ke Gong has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Immunology. Recurrent topics in Ke Gong's work include Cytokine Signaling Pathways and Interactions (8 papers), interferon and immune responses (4 papers) and Glioma Diagnosis and Treatment (4 papers). Ke Gong is often cited by papers focused on Cytokine Signaling Pathways and Interactions (8 papers), interferon and immune responses (4 papers) and Glioma Diagnosis and Treatment (4 papers). Ke Gong collaborates with scholars based in China, United States and Hong Kong. Ke Gong's co-authors include Nancy Y. Ip, Amyn A. Habib, Gao Guo, Dawen Zhao, Kimmo J. Hatanpaa, Yourong Duan, Zelda H. Cheung, Di He, Liting Wang and Fangfang Liu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Neuroscience.

In The Last Decade

Ke Gong

35 papers receiving 1.0k citations

Hit Papers

Exosome-liposome hybrid n... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer
    2022 157 citations Liting Wang, Ke Gong et al. Journal of Nanobiotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke Gong China 16 579 256 241 164 130 39 1.0k
Deyong Jia China 21 777 1.3× 389 1.5× 241 1.0× 140 0.9× 133 1.0× 33 1.2k
Amit Sharma Germany 19 674 1.2× 233 0.9× 183 0.8× 269 1.6× 110 0.8× 87 1.2k
Takatsune Shimizu Japan 20 763 1.3× 416 1.6× 259 1.1× 302 1.8× 133 1.0× 42 1.5k
Juanjuan Ou China 22 627 1.1× 313 1.2× 284 1.2× 289 1.8× 68 0.5× 39 1.3k
Ángela Sanguino United States 15 642 1.1× 358 1.4× 206 0.9× 150 0.9× 141 1.1× 33 1.3k
Esw Ngan Hong Kong 27 868 1.5× 185 0.7× 215 0.9× 120 0.7× 138 1.1× 62 1.9k
Trang Nguyen United States 19 786 1.4× 162 0.6× 284 1.2× 84 0.5× 88 0.7× 42 1.2k
Xiuli Jiang China 20 721 1.2× 335 1.3× 372 1.5× 76 0.5× 77 0.6× 50 1.4k
Eduard Yakubov Germany 19 768 1.3× 116 0.5× 141 0.6× 227 1.4× 105 0.8× 26 1.3k
Qinchuan Wang China 22 757 1.3× 266 1.0× 288 1.2× 191 1.2× 156 1.2× 50 1.3k

Countries citing papers authored by Ke Gong

Since Specialization
Citations

This map shows the geographic impact of Ke Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Gong more than expected).

Fields of papers citing papers by Ke Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Gong. The network helps show where Ke Gong may publish in the future.

Co-authorship network of co-authors of Ke Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Gong. A scholar is included among the top collaborators of Ke Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Gong. Ke Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Feng, Jun, et al.. (2025). RhoE downregulation leads to enhanced cholesterol biosynthesis and sorafenib resistance in hepatocellular carcinoma. Journal of Biological Chemistry. 301(12). 110918–110918. 1 indexed citations
3.
Gong, Ke, Zhihua Wu, Quan Wang, et al.. (2024). Nanosystem Delivers Senescence Activators and Immunomodulators to Combat Liver Cancer. Advanced Science. 11(20). e2308310–e2308310. 7 indexed citations
4.
Yang, Huiming, et al.. (2024). Rutin Attenuates Gentamycin-induced Hair Cell Injury in the Zebrafish Lateral Line via Suppressing STAT1. Molecular Neurobiology. 61(11). 9548–9561. 3 indexed citations
5.
Jiang, Wen, Feifan Li, Ke Gong, et al.. (2024). Protective Effects of Gastrodin Against Gentamicin-Induced Vestibular Damage by the Notch Signaling Pathway. Otology & Neurotology. 45(9). 1059–1067.
6.
Gong, Ke, Quan Wang, Zhihua Wu, et al.. (2023). Mitochondria-targeted nanoparticles overcome chemoresistance via downregulating BACH1/CD47 axis in ovarian carcinoma. Chinese Chemical Letters. 35(5). 108888–108888. 3 indexed citations
7.
8.
Hu, Zheng, Jia Li, Ke Gong, et al.. (2021). AKR1B10 confers resistance to radiotherapy via FFA/TLR4/NF-κB axis in nasopharyngeal carcinoma. International Journal of Biological Sciences. 17(3). 756–767. 14 indexed citations
9.
Gong, Ke, Yang Dong, Dongxiao Li, et al.. (2021). The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer. Journal of Nanobiotechnology. 19(1). 165–165. 17 indexed citations
10.
11.
Gong, Ke, Yang Dong, Liting Wang, et al.. (2020). <p>Nanoparticle BAF312@CaP-NP Overcomes Sphingosine-1-Phosphate Receptor-1-Mediated Chemoresistance Through Inhibiting S1PR1/P-STAT3 Axis in Ovarian Carcinoma</p>. International Journal of Nanomedicine. Volume 15. 5561–5571. 10 indexed citations
12.
Gong, Ke, Gao Guo, David E. Gerber, et al.. (2020). EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer. Nature Cancer. 1(4). 394–409. 51 indexed citations
13.
Gong, Ke, Zijun Gong, Xiaoling Ni, et al.. (2019). PLAC8 overexpression correlates with PD-L1 upregulation and acquired resistance to chemotherapies in gallbladder carcinoma. Biochemical and Biophysical Research Communications. 516(3). 983–990. 18 indexed citations
14.
Guo, Gao, Ke Gong, Vineshkumar Thidil Puliyappadamba, et al.. (2019). Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma. Neuro-Oncology. 21(12). 1529–1539. 24 indexed citations
15.
Guo, Gao, Ke Gong, Sonia Ali, et al.. (2017). A TNF–JNK–Axl–ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma. Nature Neuroscience. 20(8). 1074–1084. 84 indexed citations
16.
Song, Yu, Ke Gong, Wei Hong, et al.. (2014). Sj7170, a Unique Dual-function Peptide with a Specific α-Chymotrypsin Inhibitory Activity and a Potent Tumor-activating Effect from Scorpion Venom. Journal of Biological Chemistry. 289(17). 11667–11680. 13 indexed citations
17.
Gong, Ke, et al.. (2008). First-Principles Calculations of Elastic Properties of LaNi4.75Sn0.25Alloys under Pressure. Chinese Physics Letters. 25(7). 2592–2595. 1 indexed citations
18.
Cheung, Zelda H., Ke Gong, & Nancy Y. Ip. (2008). Cyclin-Dependent Kinase 5 Supports Neuronal Survival through Phosphorylation of Bcl-2. Journal of Neuroscience. 28(19). 4872–4877. 63 indexed citations
19.
He, Wei, Ke Gong, David K. Smith, & Nancy Y. Ip. (2005). The N‐terminal cytokine binding domain of LIFR is required for CNTF binding and signaling. FEBS Letters. 579(20). 4317–4323. 8 indexed citations
20.
Lai, Kwok‐On, et al.. (2004). Identification of the Jak/Stat Proteins as Novel Downstream Targets of EphA4 Signaling in Muscle. Journal of Biological Chemistry. 279(14). 13383–13392. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deyong Jia Breakdown of academic impact, for papers by Amit Sharma Breakdown of academic impact, for papers by Takatsune Shimizu Breakdown of academic impact, for papers by Juanjuan Ou Breakdown of academic impact, for papers by Ángela Sanguino Breakdown of academic impact, for papers by Esw Ngan Breakdown of academic impact, for papers by Trang Nguyen Breakdown of academic impact, for papers by Xiuli Jiang Breakdown of academic impact, for papers by Eduard Yakubov Breakdown of academic impact, for papers by Qinchuan Wang
Rankless by CCL
2026